Boai NKY Pharmaceuticals Ltd (300109) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.038x

Based on the latest financial reports, Boai NKY Pharmaceuticals Ltd (300109) has a cash flow conversion efficiency ratio of 0.038x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥139.46 Million ≈ $20.41 Million USD) by net assets (CN¥3.69 Billion ≈ $540.03 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 300109 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Boai NKY Pharmaceuticals Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Boai NKY Pharmaceuticals Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Boai NKY Pharmaceuticals Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Boai NKY Pharmaceuticals Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Cheil Worldwide KO:030000	0.000x
Cobram Estate Olives Ltd AU:CBO	-0.028x
Regis Healthcare Ltd AU:REG	-5.831x
Integra LifeSciences Holdings NASDAQ:IART	0.009x
Chengdu Haoneng Tech Co Ltd SHG:603809	0.000x
Zhejiang Garden Bio-chemical High-tech Co Ltd SHE:300401	0.021x
Zhejiang Jolly Pharmaceutical Co Ltd SHE:300181	-0.007x
Guangdong Marubi Biotechnology Co SHG:603983	0.012x

Annual Cash Flow Conversion Efficiency for Boai NKY Pharmaceuticals Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of Boai NKY Pharmaceuticals Ltd from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see 300109 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥3.66 Billion ≈ $534.86 Million	CN¥338.11 Million ≈ $49.48 Million	0.093x	+30.34%
2024-12-31	CN¥3.61 Billion ≈ $527.92 Million	CN¥256.03 Million ≈ $37.47 Million	0.071x	-48.84%
2023-12-31	CN¥3.52 Billion ≈ $515.09 Million	CN¥488.25 Million ≈ $71.45 Million	0.139x	+71.74%
2022-12-31	CN¥3.12 Billion ≈ $456.15 Million	CN¥251.77 Million ≈ $36.84 Million	0.081x	+532.17%
2021-12-31	CN¥3.40 Billion ≈ $497.55 Million	CN¥43.44 Million ≈ $6.36 Million	0.013x	-85.27%
2020-12-31	CN¥3.08 Billion ≈ $450.15 Million	CN¥266.87 Million ≈ $39.05 Million	0.087x	+232.53%
2019-12-31	CN¥3.05 Billion ≈ $446.69 Million	CN¥79.64 Million ≈ $11.65 Million	0.026x	-31.79%
2018-12-31	CN¥1.28 Billion ≈ $186.75 Million	CN¥48.81 Million ≈ $7.14 Million	0.038x	+5.36%
2017-12-31	CN¥1.30 Billion ≈ $190.58 Million	CN¥47.28 Million ≈ $6.92 Million	0.036x	-60.99%
2016-12-31	CN¥1.23 Billion ≈ $179.49 Million	CN¥114.14 Million ≈ $16.70 Million	0.093x	+68.78%
2015-12-31	CN¥1.16 Billion ≈ $170.16 Million	CN¥64.12 Million ≈ $9.38 Million	0.055x	-52.64%
2014-12-31	CN¥400.25 Million ≈ $58.57 Million	CN¥46.60 Million ≈ $6.82 Million	0.116x	+89.44%
2013-12-31	CN¥377.06 Million ≈ $55.18 Million	CN¥23.17 Million ≈ $3.39 Million	0.061x	+8.28%
2012-12-31	CN¥363.81 Million ≈ $53.24 Million	CN¥20.65 Million ≈ $3.02 Million	0.057x	+405.33%
2011-12-31	CN¥350.93 Million ≈ $51.35 Million	CN¥3.94 Million ≈ $576.77K	0.011x	-62.77%
2010-12-31	CN¥333.21 Million ≈ $48.76 Million	CN¥10.05 Million ≈ $1.47 Million	0.030x	-93.44%
2009-12-31	CN¥62.14 Million ≈ $9.09 Million	CN¥28.57 Million ≈ $4.18 Million	0.460x	+593.63%
2008-12-31	CN¥43.93 Million ≈ $6.43 Million	CN¥-4.09 Million ≈ $-598.80K	-0.093x	-117.36%
2007-12-31	CN¥17.82 Million ≈ $2.61 Million	CN¥9.56 Million ≈ $1.40 Million	0.536x	--

About Boai NKY Pharmaceuticals Ltd

SHE:300109 China Specialty Chemicals

Market Cap

$1.32 Billion

CN¥9.00 Billion CNY

Market Cap Rank

#7897 Global

#1879 in China

Share Price

CN¥18.62

Change (1 day)

+6.83%

52-Week Range

CN¥16.05 - CN¥20.47

All Time High

CN¥149.39